Phreesia ( (PHR) ) has released its Q3 earnings. Here is a breakdown of the information Phreesia presented to its investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Phreesia, Inc. is a leader in patient activation, providing digital solutions for healthcare providers and organizations to enhance patient engagement and improve healthcare outcomes in the U.S. healthcare industry.
In its latest earnings report for the third quarter of fiscal 2025, Phreesia announced a substantial revenue increase, alongside notable improvements in their financial metrics, reflecting growth in client adoption and promising future solutions.
Phreesia reported a 17% year-over-year increase in total revenue to $106.8 million, with an average healthcare services client base growing by 15%. The company significantly reduced its net loss to $14.4 million compared to $31.9 million from the previous year, and achieved a positive adjusted EBITDA of $9.8 million, a notable turnaround from a negative $6.6 million. Additionally, Phreesia generated $5.8 million in net cash from operating activities, marking a reversal from a $6.3 million cash usage a year earlier.
Looking ahead, Phreesia maintains a positive outlook for fiscal year 2025 and beyond, with expectations of continued revenue growth and improvement in operating leverage. The company anticipates reaching approximately 4,500 healthcare services clients by fiscal 2026, alongside increases in total revenue per client, supported by their robust cash position and strong operational performance.
